Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PCPG | rs61876576 | chr10:131550285 | A/G | 8.39E-6 | 174 | 24.7 | 29.43 | 14.25 | KM Plot |
| PCPG | rs61876577 | chr10:131551363 | A/G | 7.31E-6 | 176 | 24.85 | 28.35 | 14.25 | KM Plot |
| PCPG | rs61876578 | chr10:131555727 | G/A | 7.17E-6 | 177 | 25.08 | 29.43 | 14.25 | KM Plot |
| PCPG | rs61882197 | chr11:69205747 | G/A | 4.99E-5 | 176 | 25.87 | 24.5 | 6.75 | KM Plot |
| PCPG | rs61882199 | chr11:69207813 | C/T | 4.99E-5 | 176 | 25.87 | 24.5 | 6.75 | KM Plot |
| PCPG | rs61882533 | chr11:18134192 | C/T | 9.9E-5 | 172 | 25.67 | 25.87 | 9.6 | KM Plot |
| PCPG | rs61884067 | chr11:18136855 | C/T | 4.63E-6 | 175 | 26.43 | 23.48 | 10.3 | KM Plot |
| PCPG | rs61884068 | chr11:18137266 | T/C | 4.63E-6 | 175 | 26.43 | 23.48 | 10.3 | KM Plot |
| PCPG | rs61922023 | chr12:12485555 | G/A | 2.1E-8 | 171 | 25.17 | 28.47 | 7.2 | KM Plot |
| PCPG | rs61922024 | chr12:12485881 | C/A | 2.1E-8 | 171 | 25.17 | 28.47 | 7.2 | KM Plot |
| PCPG | rs61922025 | chr12:12486263 | G/A | 2.1E-8 | 171 | 25.17 | 28.47 | 7.2 | KM Plot |
| PCPG | rs61922026 | chr12:12486428 | C/G | 2.1E-8 | 171 | 25.17 | 28.47 | 7.2 | KM Plot |
| PCPG | rs61922027 | chr12:12486444 | C/T | 2.1E-8 | 171 | 25.17 | 28.47 | 7.2 | KM Plot |
| PCPG | rs619305 | chr3:80681626 | T/C | 0.000137 | 174 | 22.52 | 24.53 | 25.87 | KM Plot |
| PCPG | rs61971828 | chr13:114766822 | G/A | 0.000131 | 173 | 25.6 | 27.3 | 3.17 | KM Plot |